Corbus Pharmaceuticals Holdings (CRBP) Income towards Parent Company (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted Income towards Parent Company of -$23.34 million for Q3 2025, compared with -$13.78 million a year earlier.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Income towards Parent Company (2013 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Income towards Parent Company at Corbus Pharmaceuticals Holdings was -$67.51 million; for FY2024, it was -$40.21 million.
- In prior years, Corbus Pharmaceuticals Holdings' Income towards Parent Company was -$44.6 million in FY2023, -$42.35 million in FY2022, -$45.64 million in FY2021 and -$111.27 million in FY2020.
- The Q3 2025 figure stands as the lowest quarterly Income towards Parent Company since Q3 2020.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was -$17.66 million (Q2 2025), -$16.98 million (Q1 2025) and -$9.53 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 50.77 Mn | -465.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -23.34 Mn |
| Jun 30, 2025 | -17.66 Mn |
| Mar 31, 2025 | -16.98 Mn |
| Dec 31, 2024 | -9.53 Mn |
| Sep 30, 2024 | -13.78 Mn |
| Jun 30, 2024 | -10.00 Mn |
| Mar 31, 2024 | -6.90 Mn |
| Dec 31, 2023 | -8.02 Mn |
| Sep 30, 2023 | -10.05 Mn |
| Jun 30, 2023 | -8.78 Mn |
| Mar 31, 2023 | -17.74 Mn |
| Dec 31, 2022 | -10.88 Mn |
| Sep 30, 2022 | -8.78 Mn |
| Jun 30, 2022 | -13.25 Mn |
| Mar 31, 2022 | -9.44 Mn |
| Dec 31, 2021 | -10.26 Mn |
| Sep 30, 2021 | -2.18 Mn |
| Jun 30, 2021 | -17.14 Mn |
| Mar 31, 2021 | -16.07 Mn |
| Dec 31, 2020 | -8.61 Mn |
API Access
Corbus Pharmaceuticals Holdings Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();